Resolution of Left Atrial-Appendage Thrombus - Effects of Dabigatran in Patients With AF (RE-LATED_AF)
Effects of Dabigatran in Patients With AF - A Prospective, Randomized, Open-label, Explorative, Blinded-endpoint Trial to Compare the Efficacy of Dabigatran With Phenprocoumon for the Resolution of LAA Thrombus in Patients With AF
Sponsor: Atrial Fibrillation Network
Terminated
Recruiting problems
Other terminated trials from Atrial Fibrillation Network
Listed as NCT02256683, this PHASE2 trial focuses on Atrial Fibrillation or Atrial Flutter and Thrombosis of Left Atrial Appendage and remains terminated or withdrawn. Sponsored by Atrial Fibrillation Network, it has been updated 9 times since 2014, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Aug 2019 — Jan 2021 [monthly]
Terminated PHASE2
Status: Unknown Status → Terminated · Phase: PHASE4 → PHASE2
▶ Show 4 earlier versions
-
Jun 2018 — Aug 2019 [monthly]
Unknown Status PHASE4
-
Mar 2018 — Jun 2018 [monthly]
Unknown Status PHASE4
Status: Recruiting → Unknown Status
-
Feb 2018 — Mar 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2018 [monthly]
Recruiting PHASE4
First recorded
Jul 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Atrial Fibrillation Network
- Boehringer Ingelheim
- Johannes Gutenberg University Mainz
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bad Krozingen, Germany , Berlin, Germany , Coburg, Germany , Cologne, Germany , Dresden, Germany , Hamburg, Germany , Hanover, Germany , Karlsruhe, Germany , Leipzig, Germany , Mainz, Germany and 3 more locations